Bioequivalence of levamlodipine besylate tablets in healthy Chinese subjects: a single-dose and two-period crossover randomized study
Levamlodipine, a calcium channel blocker, has been show act as a cardiovascular drug. To compare the pharmacokinetic parameters between levamlodipine (test formulation) at a single dose of 5 mg and amlodipine ...
Source: BMC Clinical Pharmacology - Category: Drugs & Pharmacology Authors: Xin Li, Chenjing Wang, Ting Li, Yanping Liu, Shuqin Liu, Ye Tao, Yaping Ma, Xiaomeng Gao and Yu Cao Tags: Research article Source Type: research
More News: Calcium | Cardiology | Cardiovascular | China Health | Drugs & Pharmacology | Heart | Norvasc | Study